Company
InDevR
InDevR is a global leader in innovative analytical technologies that support the accelerated development and manufacturing of vaccines and other biotherapeutics.
Also known as InDevR, Inc.
- Status
- Acquiredas of 2026-09-18Source (opens in a new tab)
- Business model
- B2B
- Customers
- vaccine developers and manufacturers
- Legal name
- InDevR, Inc.
Claim, correct or request removal
Record updated 28 September 2026
About
InDevR offers both off-the-shelf and custom analytical solutions designed to expedite the development, optimization, and production of multiple types of vaccines, including mRNA, polysaccharide, conjugate, and viral vector vaccines.
Funding snapshot
- Total raised
- $10MSEC form D sum, as of 2026-09-28Source (opens in a new tab)
- Latest round
- Round, $6M2022-10-24
Funding rounds
- Round, 2022
- $6M2022-10-24, SEC form D sold, 3 investors
- Round, 2019
- $4M2019-08-29, SEC form D sold, 1 investor
About the company
- Status notes
- SSI Diagnostica Group Acquires InDevR
Products
- Hardware
- CypherOne System
- Hardware
- VaxArray Platform
Loading relationship preview